Orion OYJ Unsponsored ADR (OTCMKTS:ORINY – Get Free Report) shares reached a new 52-week high during trading on Tuesday . The company traded as high as $43.22 and last traded at $43.22, with a volume of 521 shares trading hands. The stock had previously closed at $38.54.
Orion OYJ Stock Performance
The company has a debt-to-equity ratio of 0.10, a current ratio of 1.77 and a quick ratio of 1.13. The stock has a market capitalization of $12.14 billion, a PE ratio of 17.70 and a beta of 0.08. The firm has a fifty day moving average price of $38.70 and a two-hundred day moving average price of $38.85.
Orion OYJ (OTCMKTS:ORINY – Get Free Report) last posted its quarterly earnings data on Friday, July 17th. The company reported $0.58 earnings per share (EPS) for the quarter. The company had revenue of $606.38 million during the quarter. Orion OYJ had a return on equity of 51.86% and a net margin of 28.52%.
About Orion OYJ
Orion Corporation (Orion Oyj) is a Finland-based pharmaceutical company engaged in the research, development, manufacture and marketing of human and veterinary medicines as well as diagnostic tests. The company’s core therapeutic areas include central nervous system disorders, oncology and respiratory diseases, and it offers both proprietary and generic products. Orion’s product range spans from small-molecule drugs and active pharmaceutical ingredients to radiodiagnostic imaging agents and line extensions developed through in-house research.
Since its founding in 1917 in Helsinki, Orion has grown into an integrated pharmaceuticals business with state-of-the-art manufacturing facilities in Finland and France.
Further Reading
- Five stocks we like better than Orion OYJ
- Rocket Lab Has Corrected Nearly 50%. Is It Still Too Expensive?
- Cybersecurity ETFs Are Rallying While AI Stocks Cool Off
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
Receive News & Ratings for Orion OYJ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Orion OYJ and related companies with MarketBeat.com's FREE daily email newsletter.
